文献速递区域麻醉与超声疼痛医学

双侧竖脊肌平面阻滞在门诊乳房缩小术中的随机对照试验

Evaluating the effectiveness of bilateral erector spinae plane blocks in addition to standard multimodal analgesia at reducing opioid consumption in patients undergoing elective mammoplasty in an ambulatory surgical center: a randomized clinical trial.
PubMed 文献 · Reg Anesth Pain Med · 2026-07-09

该随机对照试验纳入78例择期乳房缩小术患者,比较双侧竖脊肌平面阻滞(ESP)联合标准多模式镇痛与单纯标准镇痛的效果。结果显示ESP组24小时口服吗啡当量累积剂量降低无临床意义(10.6 vs 17.5;p=0.014),但PACU内阿片需求比例显著降低(59% vs 86.8%;p=0.006),PACU停留时间缩短(170 min vs 213 min;p=0.012)。结论认为ESP阻滞未带来临床有意义的阿片用量减少。

要点

  • ESP阻滞未显著减少24小时阿片累积用量,差异无临床意义。
  • ESP组PACU内需阿片比例更低(59% vs 86.8%),PACU停留更短。
  • 恶心呕吐、出院疼痛、24小时疼痛评分及满意度无显著差异。

核心结论

  • 乳房缩小术前实施ESP阻滞未转化为围术期阿片用量的临床有意义减少。

研究设计与样本

  • 随机对照试验,78例择期乳房缩小术患者随机分为ESP阻滞组或标准镇痛组。
  • 阻滞组接受双侧超声引导下T4水平ESP阻滞,每侧30 mL 0.25%罗哌卡因。

主要发现

  • 阻滞组24小时口服吗啡当量累积剂量为10.6,无阻滞组为17.5(p=0.014)。
  • 阻滞组PACU内需阿片比例为59%,无阻滞组为86.8%(p=0.006)。
  • 阻滞组PACU入住至出院平均170 min,无阻滞组为213 min(p=0.012)。
  • PACU恶心呕吐、出院时疼痛、24小时疼痛评分及总体麻醉满意度两组无显著差异。

临床怎么用

  • ESP阻滞可作为多模式镇痛一部分减少PACU内阿片需求和缩短PACU停留,但不应期望显著降低24小时阿片累积用量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The paravertebral block is considered the gold standard for regional anesthesia in breast surgery; however, it carries an elevated risk of pneumothorax. The erector spinae plane (ESP) block is thought to be safer. We sought to evaluate outcomes following breast reduction mammoplasty in patients treated with ESP block plus standard analgesia versus standard analgesia alone. METHODS: 78 patients were randomized to either the ESP block group or the standard analgesia group. Participants in the block group received bilateral ultrasound-guided ESP blocks with 30 mL of 0.25% ropivacaine per side at the T4 level. RESULTS: The block group reported a clinically insignificant reduction in the mean cumulative dose of oral morphine milligram equivalents used in the 24 hours postsurgery when compared with the no-block group (10.6 vs 17.5; p=0.014). Patients who received a block were discharged a mean of 170 min after post-anesthesia care unit (PACU) admission compared with the no-block group of 213 min (p=0.012). Nausea and vomiting in PACU, pain at discharge, 24-hour pain scores, and overall anesthesia satisfaction scores were not significantly different between the groups. Any opioid use during the PACU stay was significantly less in the block group, with only 59% of patients in the block group requiring opioids versus 86.8% in the no-block group (p=0.006). CONCLUSION: An ESP block prior to breast reduction mammoplasty did not translate to a clinically meaningful reduction in opioid usage in the immediate postoperative period. TRIAL REGISTRATION NUMBER: NCT03954249.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Khandaker R, Razzaki T, Aquino M, et al. Evaluating the effectiveness of bilateral erector spinae plane blocks in addition to standard multimodal analgesia at reducing opioid consumption in patients undergoing elective mammoplasty in an ambulatory surgical center: a randomized clinical trial. Reg Anesth Pain Med. 2026. PMID: 42425699. doi:10.1136/rapm-2026-107819

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。